The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.

Adam de Beaumais T, Dervieux T, Fakhoury M, Medard Y, Azougagh S, Zhang D, Yakouben K, Jacqz-Aigrain E.

Open source

DOI
10.1007/s00280-009-1205-4
Published
2009-12-23
Container
Cancer Chemother Pharmacol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-009-1205-4,
  title = {The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.},
  author = {Adam  de Beaumais T and  Dervieux T and  Fakhoury M and  Medard Y and  Azougagh S and  Zhang D and  Yakouben K and  Jacqz-Aigrain E.},
  year = {2010},
  journal = {Cancer Chemother Pharmacol},
  doi = {10.1007/s00280-009-1205-4},
  url = {https://doi.org/10.1007/s00280-009-1205-4}
}

RIS

TY  - JOUR
TI  - The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
AU  - Adam  de Beaumais T
AU  -  Dervieux T
AU  -  Fakhoury M
AU  -  Medard Y
AU  -  Azougagh S
AU  -  Zhang D
AU  -  Yakouben K
AU  -  Jacqz-Aigrain E.
PY  - 2010
JO  - Cancer Chemother Pharmacol
DO  - 10.1007/s00280-009-1205-4
UR  - https://doi.org/10.1007/s00280-009-1205-4
ER  - 

APA

T, A. D. B., T, D., M, F., Y, M., S, A., D, Z., K, Y., & E., J. (2010). The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-009-1205-4

Source records